BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2579976)

  • 1. A soluble suppressor T cell factor protects against experimental intraabdominal abscesses.
    Zaleznik DF; Finberg RW; Shapiro ME; Onderdonk AB; Kasper DL
    J Clin Invest; 1985 Mar; 75(3):1023-7. PubMed ID: 2579976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.
    Onderdonk AB; Markham RB; Zaleznik DF; Cisneros RL; Kasper DL
    J Clin Invest; 1982 Jan; 69(1):9-16. PubMed ID: 6976357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis.
    Shapiro ME; Kasper DL; Zaleznik DF; Spriggs S; Onderdonk AB; Finberg RW
    J Immunol; 1986 Jul; 137(1):341-6. PubMed ID: 3486915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immunity to Bacteroides fragilis capsular polysaccharide.
    Shapiro ME; Onderdonk AB; Kasper DL; Finberg RW
    J Exp Med; 1982 Apr; 155(4):1188-97. PubMed ID: 6174672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune T cells prevent bacteroides fragilis abscesses.
    Shapiro ME; Onderdonk AB; Kasper DL; Finberg RW
    Curr Surg; 1983; 40(2):123-6. PubMed ID: 6602035
    [No Abstract]   [Full Text] [Related]  

  • 6. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Crabb J; Bartlett JG
    J Infect Dis; 1979 Nov; 140(5):724-31. PubMed ID: 528789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of lymphokines in treatment of experimental intra-abdominal abscess caused by Bacteroides fragilis.
    Gollapudi SV; Gupta A; Thadepalli H; Perez A
    Infect Immun; 1988 Sep; 56(9):2369-72. PubMed ID: 3044996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell regulation of Bacteroides fragilis-induced intraabdominal abscesses.
    Crabb JH; Finberg R; Onderdonk AB; Kasper DL
    Rev Infect Dis; 1990; 12 Suppl 2():S178-84. PubMed ID: 2406870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis.
    Onderdonk AB; Shapiro ME; Finberg RW; Zaleznik DF; Kasper DL
    Rev Infect Dis; 1984; 6 Suppl 1():S91-5. PubMed ID: 6372042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.
    Tzianabos AO; Kasper DL; Cisneros RL; Smith RS; Onderdonk AB
    J Clin Invest; 1995 Dec; 96(6):2727-31. PubMed ID: 8675640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
    Kasper DL; Onderdonk AB
    Scand J Infect Dis Suppl; 1982; 31():28-33. PubMed ID: 6954635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preexposure of the peritoneum to live bacteria increases later mixed intraabdominal abscess formation and delays mortality.
    Sawyer RG; Adams RB; Spengler MD; Pruett TL
    J Infect Dis; 1991 Mar; 163(3):664-7. PubMed ID: 1995742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T cells mediate preexposure-induced increases in murine intraabdominal abscess formation.
    Sawyer RG; Adams RB; May AK; Rosenlof LK; Pruett TL
    Clin Immunol Immunopathol; 1995 Oct; 77(1):82-8. PubMed ID: 7554488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis.
    Gibson FC; Onderdonk AB; Kasper DL; Tzianabos AO
    J Immunol; 1998 May; 160(10):5000-6. PubMed ID: 9590249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune mechanisms in the prevention of intra-abdominal abscess formation.
    Kasper DL; Finberg RF; Crabb J; Onderdonk AB
    Scand J Infect Dis Suppl; 1989; 62():29-34. PubMed ID: 2587962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of intra-abdominal abscesses with fibrinolytic agents.
    Rosenthal GA; Quinto J; Kao J; Rotstein OD
    Can J Surg; 1988 Mar; 31(2):98-100. PubMed ID: 3127033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
    Lindberg AA; Weintraub A
    Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface antigens as virulence factors in infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Polk BF; Bartlett JG
    Rev Infect Dis; 1979; 1(2):278-90. PubMed ID: 549184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteroides fragilis-stimulated interleukin-10 contains expanding disease.
    Cohen-Poradosu R; McLoughlin RM; Lee JC; Kasper DL
    J Infect Dis; 2011 Aug; 204(3):363-71. PubMed ID: 21742834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity.
    Kalka-Moll WM; Tzianabos AO; Wang Y; Carey VJ; Finberg RW; Onderdonk AB; Kasper DL
    J Immunol; 2000 Jan; 164(2):719-24. PubMed ID: 10623815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.